Search results
6 mar 2024 · — New clinical trial data for bemdaneprocel, a promising stem cell-derived therapy for Parkinson’s disease, continues to show positive results 18 months after treatment, scientists reported today at an international conference in Portugal.
- Stem-cell therapy shows promise for Parkinson's disease
After decades of researching and treating Parkinson's...
- Stem-cell therapy shows promise for Parkinson's disease
11 sty 2024 · After decades of researching and treating Parkinson's disease, UCI Health neurologist Dr. Claire Henchcliffe reports promising results a first-in-human clinical trial of stem cells engineered to replace dopamine-producing neurons destroyed by the disease.
In a first-in-human clinical trial, researchers are assessing the safety of dopamine-producing stem cells that are surgically implanted in the brain of patients whose Parkinson’s disease has progressed to the point where existing medications no longer work to control their movements.
Clinical Trials and Progress in Florida. Florida's research institutions are actively involved in clinical trials to evaluate the safety and efficacy of stem cell therapy for Parkinson's Disease. These trials aim to assess the transplantation methods, dosage, and long-term outcomes of stem cell treatments.
7 wrz 2023 · We systematically identified all clinical trials investigating cell- or tissue-based therapies for PD published before July 2023. Out of those, studies reporting transplantation of homogenous cells (containing one cell type) were included in meta-analysis.
The research, published in Stem Cells and Development on June 22, 2023, is a crucial step forward for clinical trials of autologous iPSC-derived neurons in human patients with...
29 wrz 2021 · Neurosurgeon Viviane Tabar is co-leading a trial to inject stem cells into the brains of people with Parkinson’s disease to restore dopamine levels.
